Amplitude Surgical SASAMPLI 
9.15%24h
Amplitude Surgical SAS (AMPLI) Stock Overview
Amplitude Surgical SA develops and markets products for orthopedic surgery. The company provides a range of orthopedic products for primary and revision surgery aimed at treating pathologies of the hip, knee, and lower extremities primarily for foot and ankle surgery. It also offers AMPLIVISION, a computer-assisted surgical system; the i.M.A.G.E., a single-use made-to-measure instrument system; and E.T.O.I.L.E, a technology platform for anterior approaches resulting in less-invasive surgery. In addition, the company provides instruments for fitting related accessories. It sells its products through a network of distributors and agents in approximately 30 countries. The company serves patients, surgeons, and healthcare facilities. Amplitude Surgical SA was founded in 1997 and is headquartered in Valence, France. The company operates as a subsidiary of Auroralux SAS.
AMPLI Stock Information
Amplitude Surgical SAS (AMPLI) Price Chart
Amplitude Surgical SAS Overview: Key Details and Summary
Stock data | 2023 | Change |
|---|---|---|
| Price | $3.71 | N/A |
| Market Cap | $178.15M | N/A |
| Shares Outstanding | 47.99M | -0.07% |
| Employees | 388.00 | N/A |
| Shareholder Equity | 95.81M | 82.27% |
Valuation | 2023 | Change |
|---|---|---|
| P/S Ratio | 1.60 | N/A |
| P/B Ratio | 1.86 | N/A |
Growth | 2023 | Change |
|---|---|---|
| Return on Equity | 0.4469 | N/A |
Earnings | 2023 | Change |
|---|---|---|
| Revenue | $111.37M | N/A |
| Earnings | $42.82M | N/A |
| Gross Margin | 0.7887 | N/A |
| Operating Margin | 0.0723 | N/A |
| Net income margin | 0.3845 | N/A |
Financial Strength | 2023 | Change |
|---|---|---|
| Total Assets | $295.67M | N/A |
| Total Debt | $118.35M | N/A |
| Cash on Hand | $41.36M | N/A |
| Debt to Equity | $1.97 | -54.87% |
| Cash to Debt | 0.3495 | 130.99% |
| Current Ratio | $2.31 | 4.76% |
